IL17A and cancer: IL-17A participates in tumor angiogenesis by binding to its receptor on vascular endothelium, promoting angiogenesis and inflammatory response, possibly engaging the IL-17-STEAP4-XIAP pathway and contributing to the immortalization of cancer cells [138,139].